title: MRSA: The Private-Sector Response.
abstract: With Medicare eliminating payment for the treatment of several preventable hospital errors and infections, the market for effective infection-control interventions is poised to grow quickly. Products that merge information technology with biotechnology can improve quality of care, reduce unnecessary suffering, and eliminate waste of resources.
authors.affiliation: Virginia Jackson is a second-year medical student at Jefferson Medical College of Thomas Jefferson University, Philadelphia. She can be reached at «  virginia.jackson@jefferson.edu ».David B. Nash, MD, MBA, is the Dr. Raymond C. and Doris N. Grandon Professor and chairman of the Department of Health Policy at Jefferson Medical College. Nash also chairs Biotechnology Healthcare's editorial advisory board. He can be reached at «  david.nash@jefferson.edu »
authors.forename: Virginia
authors.initials: V
authors.lastname: Jackson
authors.forename: David B
authors.initials: DB
authors.lastname: Nash